CXCL11 and glioblastoma: Systemic delivery of oncolytic viruses in glioblastoma (GBM) has been challenging; however, encapsulating CXCL11-modified oncolytic adenovirus with tannic acid and Fe3+ has extended circulation time and reshaped the tumor immune microenvironment effectively [142].